Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-01-10

FDA Approved: ROPINIROLE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for ropinirole submitted by Alembic Pharmaceuticals Limited (ANDA 202786).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ropinirole (ropinirole)

Snippet

SUPPL AP for ROPINIROLE (ROPINIROLE)